High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
Not Applicable
Completed
- Conditions
- Prostatic Neoplasm
- Registration Number
- NCT00126854
- Lead Sponsor
- AHS Cancer Control Alberta
- Brief Summary
The purpose of this study is to establish the correct scanning parameters for obtaining good quality 3 Tesla (3T) magnetic resonance spectroscopy images (MRSI) of the prostate gland before and after brachytherapy implantation for prostate cancer. Three Tesla MRSI may be a valuable additional diagnostic and follow-up investigation for prostate cancer patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
- Suitable candidate for prostate brachytherapy to treat prostate cancer
- Patient signs a study consent form
Exclusion Criteria
- Have received other radiotherapy for prostate cancer or hormone treatments
- Has contraindication to MRSI scanning
- Does not sign study consent form
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method pilot study meant to establish scanning parameters on 3T MRSI
- Secondary Outcome Measures
Name Time Method safety/toxicity
Trial Locations
- Locations (1)
Cross Cancer Institute
🇨🇦Edmonton, Alberta, Canada